Aerie Pharmaceuticals, Inc. Earnings Per Share (Diluted)
Aerie Pharmaceuticals, Inc. reported Earnings Per Share (Diluted) of -$0.56 per share for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2022-11-04
- Aerie Pharmaceuticals, Inc. earnings per share, diluted for the quarter ending 2022-09-30 was -$0.56.
- Aerie Pharmaceuticals, Inc. earnings per share, diluted for the quarter ending 2022-06-30 was -$0.41.
- Aerie Pharmaceuticals, Inc. earnings per share, diluted for the quarter ending 2022-03-31 was -$0.76.
- Aerie Pharmaceuticals, Inc. earnings per share, diluted for the quarter ending 2021-12-31 was $0.98.
- Aerie Pharmaceuticals, Inc. earnings per share, diluted for fiscal 2021 was -$1.61.
- Aerie Pharmaceuticals, Inc. earnings per share, diluted for fiscal 2020 was -$3.99.
- Aerie Pharmaceuticals, Inc. earnings per share, diluted for fiscal 2019 was -$4.39.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$0.56 10-Q · filed 2022-11-04 | -$0.97 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$1.72 10-Q · filed 2022-11-04 | -$0.77 derived: net income ÷ weighted average shares · filed 2022-11-04 |
| 2022-06-30 | -$0.41 10-Q · filed 2022-08-05 | -$1.16 10-Q · filed 2022-08-05 | -$0.21 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$1.05 derived: net income ÷ weighted average shares · filed 2022-11-04 |
| 2022-03-31 | -$0.76 10-Q · filed 2022-05-06 | $0.20 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$0.64 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$1.47 derived: net income ÷ weighted average shares · filed 2022-11-04 |
| 2021-12-31 | $0.98 derived: net income ÷ weighted average shares · filed 2022-02-25 | $0.13 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$0.71 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$1.61 10-K · filed 2022-02-25 |
| 2021-09-30 | -$0.86 10-Q · filed 2022-11-04 | -$1.69 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$2.60 10-Q · filed 2022-11-04 | -$3.61 derived: net income ÷ weighted average shares · filed 2022-11-04 |
| 2021-06-30 | -$0.84 10-Q · filed 2022-08-05 | -$1.75 10-Q · filed 2022-08-05 | -$2.75 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$3.61 derived: net income ÷ weighted average shares · filed 2022-11-04 |
| 2021-03-31 | -$0.91 10-Q · filed 2022-05-06 | -$1.91 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$2.78 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$3.83 derived: net income ÷ weighted average shares · filed 2022-11-04 |
| 2020-12-31 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$1.87 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$2.92 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$3.99 10-K · filed 2022-02-25 |
| 2020-09-30 | -$0.86 10-Q · filed 2021-11-05 | -$1.91 derived: net income ÷ weighted average shares · filed 2021-11-05 | -$2.99 10-Q · filed 2021-11-05 | |
| 2020-06-30 | -$1.05 10-Q · filed 2021-08-05 | -$2.12 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | -$4.39 10-K · filed 2022-02-25 |